Elongation Factor 2 in Cancer: A Promising Therapeutic Target
Author Information
Author(s): Jia Xuechao, Huang Chuntian, Liu Fangfang, Dong Zigang, Liu Kangdong
Hypothesis
The review explores the role of eEF2 in cancer and its potential as a therapeutic target.
Conclusion
eEF2 plays a critical role in cancer progression and treatment resistance, making it a promising target for novel therapies.
Supporting Evidence
- eEF2 is overexpressed in several cancers, correlating with poor patient prognosis.
- Targeting eEF2 has shown potential therapeutic benefits in advanced carcinomas.
- eEF2 modifications contribute to chemotherapy resistance in colorectal cancer.
Takeaway
eEF2 is a protein that helps make other proteins in our body, and when it doesn't work right, it can help cancer grow. Scientists think that fixing eEF2 could help treat cancer.
Methodology
This is a mini review summarizing recent advancements in the structure, activity, and potential inhibitors of eEF2.
Limitations
The review highlights the need for further research into the precise functions and mechanisms of eEF2 in cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website